DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin
9 November 2025

DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont de Nemours, Inc. headlines today with a fresh analyst target bump and continued investor focus on the company’s post‑spinoff profile, dividend reset, and buyback plans.


Key takeaways

  • Citi raises its DD target to $47 and reiterates a “Buy” rating. MarketBeat
  • “New DuPont” declares a $0.20 quarterly dividend (payable Dec. 15 to holders of record Nov. 28) and authorizes a $2B share repurchase, including a $500M accelerated buyback. dupont.com
  • Qnity Electronics spinoff completed (1 Qnity share for every 2 DuPont shares, distribution Nov. 1); Qnity now trades on the NYSE as “Q” and joins the S&P 500. investors.dupont.com+1
  • Q3 2025 for continuing ops: net sales $3.07B (+7% y/y), adj. EPS $1.09, operating EBITDA $840M; FY25 operating EBITDA guidance raised to $1.6B; Q4 guide: adj. EPS ~$0.43, sales ~$1.69B.

What’s new today (Nov. 9, 2025)

  • Citi lifts DuPont target to $47. The move keeps a “Buy” stance and follows last week’s earnings, dividend reset, and buyback announcement. MarketBeat
  • Dividend coverage: Financial outlet Simply Wall St notes the new $0.20 per‑share payout is lower than last year’s comparable quarterly dividend, reflecting DuPont’s reshaped, smaller post‑spin earnings base. (DuPont’s board approved the new payout on Nov. 6.
  • Fund flow footnote: MarketBeat flagged a 13F‑style update showing Resona Asset Management modestly increased its DD position; such filings often lag by weeks but add context to institutional ownership.

The bigger picture: A pivotal week for “new DuPont”

Qnity Electronics is out; DuPont refocuses. DuPont completed the tax‑free separation of Qnity on Nov. 1 (1 share of Qnity for every 2 DD shares; ~209M Qnity shares distributed). Qnity began “regular‑way” trading on Nov. 3 as NYSE: Q and was added to the S&P 500 at launch—an unusual debut that broadens index fund ownership. investors.dupont.com+1

Capital returns accelerate. On Nov. 6, DuPont unveiled a $2B repurchase authorization and plans to launch a $500M accelerated share repurchase (ASR). The board also set a $0.20 quarterly dividend for “new DuPont,” payable Dec. 15 to holders of record Nov. 28. Management simultaneously raised FY25 operating EBITDA guidance to $1.6B for the continuing business. dupont.com

Quarterly scorecard. For Q3 2025 continuing operations, DuPont reported net sales of $3.07B (+7% y/y), adjusted EPS of $1.09, and operating EBITDA of $840M. It also posted $591M in cash from operations and $576M in transaction‑adjusted free cash flow.

Looking to Q4. DuPont guided to ~$0.43 in adjusted EPS and ~$1.69B in sales—slightly below consensus—reflecting the recent portfolio changes (Qnity spin and Aramids reclassification).

Balance sheet context. Ahead of the spin, Qnity’s board approved a cash “midnight dividend” of about $4.122B and related interest deposit tied to its debt, a step that supported DuPont’s capital return flexibility post‑separation. Reuters

Portfolio simplification continues. DuPont also reached a deal to divest its Aramids business (Kevlar®, Nomex®) to Arclin for ~$1.8B, expected to close in Q1 2026, further concentrating the portfolio.

Product news to watch. In Worker Safety, DuPont introduced Tyvek® APX™ on Nov. 4—new protective garments emphasizing breathability without sacrificing protection—adding an innovation angle to the Water & Protection segment narrative.

What it means for investors

  • Reset and return: The reduced $0.20 dividend aligns with the smaller earnings base after the electronics separation and is paired with a sizable $2B buyback—an explicit shift toward flexible capital returns while the “new DuPont” scales margin and cash conversion. dupont.com
  • Focus, not breadth: With Qnity independent and Aramids set to be divested, DuPont is leaning into advanced materials for healthcare, water, and industrial end‑markets, where it lifted FY25 operating EBITDA guidance to $1.6B. Execution vs. Q4 guidance—and buyback pacing—are the near‑term watch‑items.
  • Coverage turning constructive: Today’s Citi target increase to $47 underscores a cautious but improving sell‑side stance as the post‑spin model settles.

Dates & details investors should know

  • Dividend: $0.20 per share; Record Date: Nov. 28, 2025; Payable: Dec. 15, 2025.
  • Qnity distribution: 1 Q share for every 2 DD shares (distribution date: Nov. 1, 2025); Q now trades on the NYSE and is in the S&P 500.

Tickers: DD (DuPont de Nemours), Q (Qnity Electronics)


Disclosure: This article is for information purposes only and does not constitute investment advice or a recommendation to buy or sell any securities.

Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Blue Origin’s New Glenn Set to Launch NASA’s ESCAPADE to Mars Today (Nov. 9): Liftoff at 2:45 p.m. ET — How to Watch, Weather, Flight Plan & What’s Onboard
Previous Story

Blue Origin’s New Glenn Set to Launch NASA’s ESCAPADE to Mars Today (Nov. 9): Liftoff at 2:45 p.m. ET — How to Watch, Weather, Flight Plan & What’s Onboard

Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead
Next Story

Viking Therapeutics (VKTX) Today — Nov 9, 2025: New Institutional Buying, Fresh Technical Levels, and Key Catalysts Ahead